I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 7 studies | 21% ± 6% | |
| non-classical monocyte | 6 studies | 31% ± 14% | |
| classical monocyte | 5 studies | 29% ± 12% | |
| B cell | 5 studies | 27% ± 6% | |
| epithelial cell | 5 studies | 40% ± 17% | |
| endothelial cell | 5 studies | 22% ± 6% | |
| CD4-positive, alpha-beta T cell | 4 studies | 21% ± 4% | |
| mature NK T cell | 4 studies | 17% ± 1% | |
| leukocyte | 3 studies | 21% ± 4% | |
| CD8-positive, alpha-beta T cell | 3 studies | 23% ± 8% | |
| conventional dendritic cell | 3 studies | 35% ± 12% | |
| hematopoietic precursor cell | 3 studies | 27% ± 9% | |
| ciliated cell | 3 studies | 28% ± 7% | |
| CD8-positive, alpha-beta memory T cell | 3 studies | 21% ± 5% | |
| dendritic cell | 3 studies | 38% ± 18% | |
| gamma-delta T cell | 3 studies | 29% ± 15% | |
| plasmacytoid dendritic cell | 3 studies | 22% ± 3% |
